Skip to main content
Signal8

PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)

Panacea Life Sciences Holdings, Inc. operates as an integrated research and production firm, specializing in cannabinoid and nutraceutical products across the entire supply chain, from sourcing to final sale. Its core mission is to develop and deliver natural, pharmaceutical-grade alternatives for both human and pet consumption. The company's diverse product range encompasses items such as softgels, edible gummies, liquid tinctures, sublingual tablets, and a variety of cosmetic and topical applications. In addition to these offerings, the company is involved in the personal protective equipment (PPE) market, importing and distributing hand sanitizers and masks. Panacea Life Sciences also provides white-label and contract manufacturing services to other cannabinoid companies, sells raw materials, and manages tolling arrangements. Established in 2008, the company is headquartered in Greenwood Village, Colorado.

Sector: Medicinal Chemicals & Botanical Products

Industry: Drug Manufacturers - Specialty & Generic

Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc.

OTC:PLSHHealthcare
-5.00%$0.0798
Mkt Cap$1.41M
Float14.81M
O/S17.65M
Inst Own-
SI0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$911K
Net Income-$417K
Total Assets$5.6M
Free Cash Flow$617K
Debt & Equity
Debt 4%
Equity 96%
Preferred 0%
Total Debt$215K
Total Equity$5.38M
Preferred Stock$1K
Shares Outstanding
Short Interest
Split History1 split
  1. 20:1Forward split
    Dec 28, 20161 share → 20
Balance Sheet Details
Assets$5.6M
Liabilities$215K
Accounts Receivable$0
Accounts Payable$0
Inventory$3.28M
PP&E (Net)$1.41M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue$911K$4.11M$2.38M$1.63M$2.06M$9.02M$346K$0$0$0$213
YoY Growth-77.8%72.2%46.6%-21.0%-77.2%2508.7%-----
Cost of Revenue$2.13M$1.26M$6.47M$1.23M$1.52M$7.02M$2.05M$0$0$0$21K
Gross Profit-$1.22M$2.85M-$4.09M$396K$541K$2M-$1.7M$0$0$0-$20K
Gross Margin-133.9%69.4%-171.5%24.4%26.2%22.2%-491.9%----9583.1%
Research and Development$0$0$0$0$0$0$22K$300K$356K$369K$77K
Selling, General, and Administrative$534K$5.42M$1.46M$1.09M$1.52M$2.81M$8.95M$2.14M$1.64M$1.23M$290K
Other$0$0$5.21M$4.7M$4.56M$4.45M$0$0$0$0$291K
Total Operating Expenses$534K$5.42M$2.37M$5.79M$6.08M$7.26M$8.97M$2.44M$2M$1.6M$367K
Operating Income (EBIT)-$1.75M-$2.58M-$5.55M-$5.4M-$5.54M-$5.26M-$10.67M-$2.44M-$2M-$1.6M-$368K
Operating Margin-192.6%-62.7%-232.5%-331.8%-269.0%-58.3%-3087.5%----172976.5%
Interest Expense$966K$1.83M$1.56M$2.05M$1.11M$1.51M$479K-$464K-$69K$0$0
Interest Income$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)$1.34M$1.99M-$2.47M-$3.49M$1.15M$26K$654K-$1.9M-$1.86M-$6K$10K
Income Before Tax (EBT)-$417K-$583K-$8.02M-$9.14M-$4.78M-$5.23M-$10.02M-$4.34M-$3.86M-$1.6M-$358K
Income Tax Expense$0$0$0$0$0$0$0$0$0$0$3
Net Income-$417K-$583K-$8.02M-$11.1M-$6.12M-$6.99M-$9.48M-$4.34M-$3.86M-$1.6M-$358K
Net Income Margin-45.8%-14.2%-336.1%-682.1%-297.3%-77.6%-2742.8%----168064.3%
Supplementary Data
EPS-0.01-0.03-0.48-0.75-0.34-0.41-7.83-25.49-0.23-18.68-156.61
Diluted EPS-0.01-0.03-0.48-0.75-0.34-0.41-7.83-25.49-0.23-18.68-156.61
Weighted Average OS59.47M18.43M16.63M14.86M17.82M16.92M1.21M170,14416.87M85,8062,286
EBITDA$18K$2.39M-$4.75M-$5.36M-$2M-$2.09M-$8.65M-$3.48M-$3.12M-$1.6M-$356K
EBITDA Margin2.0%58.3%-199.0%-329.6%-97.2%-23.2%-2501.6%----167300.5%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Assets
Current Assets
Cash and Cash Equivalents$41K$1.47M$101K$7K$20K$84K$18K$2K$161K$1.06M$72K
Short-Term Investments$0$3K$15K$1.11M$3.79M$2.85M$0$0$0$0$0
Cash and Short-Term Investments$41K$1.47M$116K$1.11M$3.81M$2.94M$18K$2K$161K$1.06M$72K
Accounts Receivable$0$233K$264K$706K$744K$147K$202K$0$0$0$7K
Inventory$3.28M$3.66M$4.01M$4.45M$4.26M$8.41M$1.34M$0$0$0-$79K
Other Current Assets$0$0$263K$113K$0$27K$871K$0$0$0$79K
Total Current Assets$3.32M$5.36M$4.66M$6.38M$9.1M$11.52M$2.43M$14K$173K$2.08M$79K
Long-Term Assets
Property, Plant & Equipment Net$1.41M$4.01M$10.31M$10.92M$12.44M$17.53M$868K$0$0$0$1K
Goodwill$0$1.85M$3.01M$2.19M$2.19M$2.19M$2.19M$0$0$0$0
Intangible Assets$0$0$0$0$61K$123K$184K$0$0$50K$0
Long-Term Investments$860K$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$2.35M$0$0$0$4K
Total Long-Term Assets$2.27M$5.85M$13.33M$13.11M$14.69M$19.84M$5.59M$0$0$50K$6K
Other Assets$0$0$0$0$0$0$0$0$0$0$0
Total Assets$5.6M$11.22M$17.98M$19.49M$23.78M$31.36M$8.02M$14K$173K$2.13M$85K
Liabilities
Current Liabilities
Accounts Payable$0$4.68M$4.28M$2.3M$1.69M$1.77M$1.9M$0$0$0$75K
Short-Term Debt$215K$10.8M$11.9M$10.32M$6.76M$15.33M$311K$543K$106K$0$101K
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$368K-$1.69M-$2.03M$215K-$923K-$735K$0$0
Other Current Liabilities$0$0$3.26M$0$0$0$1.39M$3K$2.28M$58K$2K
Total Current Liabilities$215K$15.48M$19.45M$15.07M$10.07M$18.26M$3.81M$3K$2.39M$625K$178K
Long-Term Liabilities
Long-Term Debt$0$3.57M$3.57M$3.57M$3.26M$2.7M$100K$100K$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$0$3.99M$6.83M$6.56M$6.61M$6.39M$321K$100K$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$215K$19.47M$26.27M$21.63M$16.68M$24.65M$4.13M$3.44M$2.39M$625K$178K
Stockholders' Equity
Preferred Stock$1K$1K$1K$852$853$102$953$1K$1K$1K$0
Common Stock$6K$2K$2K$1K$1K$2K$4K$623$4K$3K$2K
Retained Earnings-$34.92M-$34.51M-$33.92M-$25.91M-$16.77M-$11.98M-$20.92M-$10.54M-$6.2M-$2.34M-$737K
Comprehensive Income & Other$0$0-$385$0-$0-$128K$66-$623-$280-$280$0
Other Stockholders' Equity$40.3M$26.25M$25.63M$23.76M$23.87M$18.69M$25.34M$7.11M$3.98M$3.84M$642K
Total Equity$5.38M-$8.25M-$8.29M-$2.14M$7.1M$6.71M$4.43M-$3.42M-$2.22M$1.5M-$93K
Minority Interest$0$0$0$0$0-$2.02M-$537K$0$0$0$0
Total Liabilities and Equity$5.6M$11.22M$17.98M$19.49M$23.78M$31.36M$8.55M$14K$173K$2.13M$85K
Supplementary Data
Total Debt$215K$14.79M$18.73M$18.97M$15M$22.89M$632K$643K$106K$0$101K
Net Debt$173K$13.33M$18.63M$18.96M$14.98M$22.8M$614K$641K-$55K-$1.06M$29K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Operating Activities
Net Income-$417K-$583K-$8.02M-$9.14M-$4.78M-$5.23M-$9.48M-$4.34M-$3.86M-$1.6M-$358K
Depreciation & Amortization$1.77M$1.15M$1.71M$1.73M$1.68M$1.63M$892K$405K$53K$0$2K
Deferred Income Tax$0$0$0$0$0-$1.32M-$1.15M$0$0$0-$85K
Stock-Based Compensation$0$0$0$0$0$1.32M$3.77M$0$0$100K$5K
Changes in Working Capital:
  Accounts Receivable$233K$31K$431K$38K-$97K$152K-$107K$0$0$0-$213
  Inventory-$95K$352K$297K-$184K-$548K-$5.05M-$2.86M$0$0$0$0
  Accounts Payable-$4.68M$57K$1.99M$1.08M$1.07M$685K$973K$188K$210K$491K$85K
  Other Working Capital-$94K-$1.95M$318K$624K$208K$1.39M$302K$1.14M$777K$528K-$2K
Total Working Capital Change-$4.63M-$1.51M$3.03M$1.56M$632K-$2.82M-$1.7M$1.14M$777K$528K$82K
Other Non-Cash Items$3.9M$1.63M$1.74M$3.45M-$1.45M-$1.22M$8.32M$2.73M$1.85M$111K-$375K
Net Cash from Operating$617K$689K-$1.52M-$2.4M-$3.92M-$7.65M-$5.75M-$466K-$1.23M-$963K-$568K
Investing Activities
Capital Expenditures$0-$41K-$65K-$244K-$163K-$3.2M-$541K$0$0$0$0
Acquisitions$0$1.38M$0$0$9K$120K-$1.5M$0$0$1K$0
Purchases of Investments-$60K$0$0$0$0$3.08M$0$0$0$0$0
Sales of Investments$0$0$0$47K$446K$120K$0$0$0$0$0
Other Investing Activities$0$0-$0$47K$230K-$120K$0$0$0$1K$0
Net Cash from Investing-$60K$1.38M-$65K-$197K$523K-$3.08M-$2.04M$0$0$1K$0
Financing Activities
Debt Repaid-----$3.09M-$2.02M-$716K-$257K-$316K--
Common Stock Issuance$0$0$0$55K$4.37M$385K$7.22M$50K$25K$2M$0
Common Stock Repurchases$0$0$0$0$0$0$1.44M$0$0-$50K$0
Dividends Paid$0$0$0$0$0$0-$904K$0$0$0$0
Other Financing Activities$0$0$1.68M$0$0$273K-$128K$0$0$0$598K
Net Cash from Financing-$1.98M-$707K$1.68M$2.58M$3.33M$2.3M$7.8M$307K$341K$1.95M$598K
Forex Effect$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$1.43M$1.37M$94K-$13K-$65K-$8.43M$16K-$159K-$894K$983K$31K
Supplementary Data
Operating Cash Flow$617K$689K-$1.52M-$2.4M-$3.92M-$7.65M-$5.75M-$466K-$1.23M-$963K-$568K
Capital Expenditure$2-$5-$65K-$244K-$163K-$3.2M-$541K$0$0$0$0
Free Cash Flow$617K$689K-$1.59M-$2.64M-$4.09M-$10.85M-$6.29M-$466K-$1.23M-$963K-$568K
Cash at Beginning$1.47M$101K$7K$20K$84K$8.52M$2K$161K$1.06M$72K$42K
Cash at End$41K$1.47M$101K$7K$20K$84K$18K$2K$161K$1.06M$72K